The objective of this article is to define disease onset pattern and understand the response to therapy in children with systemic lupus erythematosus (SLE) in Egypt.
Methods
A prospective cohort of 41 Egyptian children diagnosed with SLE was analyzed. SLE Disease Activity Index (SLEDAI) score was used to record disease activity at onset, and renal biopsy was performed to define the stage of lupus nephritis. Response to therapy over a follow-up period ranging from 10 to 50 months was evaluated.
Results
The mean age at diagnosis was 12.12 ± 3.45 years. Thirty-six (87.8%) patients were females. Most patients had multiple manifestations at onset. The most common presenting symptoms were pallor and fever (51.2% and 43.9%, respectively). Lupus nephritis was found in 27 (65.9%) children. International Society of Nephrology (ISN) classes I and III were the most common findings on renal biopsy. Neuropsychiatric manifestations were present at disease onset in 19 patients (46.3%) with a bad prognostic course. At diagnosis, high SLEDAI scores were recorded (mean: 29.95 ± 2.06). The mean renal SLEDAI score was 10.2 ± 4. At follow-up 16 (39.02%) patients were in complete remission, 10 (24.39%) were in partial remission, two (4.87%) had active disease, five (12.9%) had relapsed, four (9.75%) had died and four (9.75%) patients were lost to follow-up.
Conclusions
Egyptian children with SLE appear to have severe disease on presentation with high SLEDAI scores and high prevalence of lupus nephritis, but respond well to therapy with a favorable short-term prognosis.
ArdoinSPSchanbergLEChapter 152: Systemic lupus erythematosus. In: KliegmanRMStantonBFSt. GemeJWIIISchorNFBerhrmanRE (eds). Nelson textbook of pediatrics, 19th ed. Philadelphia: Saunders Company, 2011.
2.
BrunnerHIGladmanDDIbañezDUrowitzMDSilvermanED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum2008; 58: 556–562.
3.
HirakiLTFeldmanCHLiuJ. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum2012; 64: 2669–2676.
4.
DanchenkoNSatiaJÁAnthonyMS. Epidemiology of systemic lupus erythematosus: A comparison of worldwide disease burden. Lupus2006; 15: 308–318.
BertsiasGIoannidisJPBoletisJ. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis2008; 67: 195–205.
HochbergM. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
11.
BertsiasGKIoannidisJPAringerM. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: Report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis2010; 69: 2074–2823.
12.
WeeningJJD’AgatiVDSchwartzMM. The classification of glomerulonephritis in systemic lupus erythematosus. J Am Soc Nephrol2004; 15: 241–250.
13.
CostallatLTCoimbraAM. Systemic lupus erythematosus: Clinical and laboratory aspects to age at disease onset. Clin Exp Rheumatol1994; 12: 603–607.
14.
Le Thi HuongDWeschlerBPietteJC. Clinical manifestations and outcome of childhood systemic lupus erythematosus: A retrospective study of 50 cases. Eur J Int Med1993; 4: 15–22.
15.
HashimotoHTsudaHHiranoTTakasakiYMatsumotoTHiroseS. Differences in clinical and immunological findings of systemic lupus erythematosus related to age. J Rheumatol1987; 14: 497–501.
16.
TuckerLBMenonSSchallerJGIsenbergDA. Adult- and childhood-onset systemic lupus erythematosus: A comparison of onset, clinical features, serology, and outcome. Br J Rheumatol1995; 34: 866–872.
17.
ManziS. Epidemiology of systemic lupus erythematosus. Am J Manag Care2001; 7: 474–479.
18.
DelignyCThomasLDubreuilF. Systemic lupus erythematosus in Martinique: An epidemiologic study [article in French]. Rev Med Interne2002; 3: 21–29.
19.
ParimalamKArunprasathPKayalvizhiVASarathaKPManoharanR. Pediatric SLE—is CNS involvement a poor prognostic sign?E-Journal of the Indian Society of Teledermatology2011; 5: 4–10.
20.
UthmanINasrFKassakKMasriAF. Systemic lupus erythematosus in Lebanon. Lupus1999; 8: 713–715.
21.
Al-JarallahKAl-AwadiASiddiquiH. Systemic lupus erythematosus in Kuwait—hospital based study. Lupus1998; 7: 434–438.
22.
HopkinsonNDDohertyMPowellRJ. Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis1994; 53: 675–680.
23.
Al-AttiaHM. Clinico-laboratory profile of 33 Arabs with systemic lupus erythematosus. Postgrad Med J1996; 72: 677–699.
24.
AliUSDalviRBMerchantRH. Systemic lupus erythematosus in Indian children. Indian Pediatr1989; 26: 868–873.
25.
FallerGThomsonPDKalaUKHahnD. Demographics and presenting clinical features of childhood systemic lupus erythematosus. S Afr Med J2005; 95: 424–427.
26.
UzielYGorodnitskiNMukamelM. Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus. Lupus2007; 16: 142–146.
27.
DungNTLoanHTNielsenSZakMPetersenFK. Juvenile systemic lupus erythematosus onset patterns in Vietnamese children: A descriptive study of 45 children. Pediatr Rheumatol Online J2012; 10: 38–38.
28.
FontJCerveraREspinosaG. Systemic lupus erythematosus (SLE) in childhood: Analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis1998; 57: 456–459.
29.
BalkaranBNRobertsLARamcharanJ. Systemic lupus erythematosus in Trinidadian children. Ann Trop Paediatr2004; 24: 241–244.
30.
SupavekinSChatchomchuanWPattaragarnASuntornpochVSumboonnanondaA. Pediatric systemic lupus erythematosus in Siriraj Hospital. J Med Assoc Thai2005; 88: 115–123.
31.
AlsaeidKKamalHHaiderMZAl-EneziHMMalaviyaAN. Systemic lupus erythematosus in Kuwaiti children: Organ system involvement and serological findings. Lupus2004; 13: 613–617.
32.
PluchinottaFRSchiavoBVittadelloFMartiniGPerilongoGZulianF. Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes. Lupus2007; 16: 550–555.
33.
PattaragarnASumboonnanondaAParichatikanondPSupavekinSSuntornpochVVongjiradA. Systemic lupus erythematosus in Thai children: Clinicopathologic findings and outcome in 82 patients. J Med Assoc Thai2005; 8: 232–241.
34.
Ramírez GómezLAUribe UribeOOsio UribeO. Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children. Lupus2008; 1: 596–604.
35.
BahabriSSabbanEAAl RashedA. Juvenile systemic lupus erythematosus in 60 Saudi children. Ann Saudi Med1997; 17: 612–615.
36.
MokCCMakAChuWPToCHWongSN. Long-term survival of southern Chinese patients with systemic lupus erythematosus: A prospective study of all age groups. Medicine (Baltimore)2005; 84: 218–224.
37.
TakeiSMaenoNShigemoriM. Clinical features of Japanese children and adolescents with systemic lupus erythematosus: Results of 1980–1994 survey. Acta Paediatr Jpn1997; 39: 250–256.
38.
GedaliaAMolinaJFMolinaJUribeOMalagonCEspinozaLR. Childhood-onset systemic lupus erythematosus: A comparative study of African-Americans and Latin Americans. J Natl Med Assoc1999; 91: 497–501.
39.
Al ArfajASKhalilN. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. Lupus2009; 18: 465–473.
40.
Al-MayoufSAbdwaniRAl-BrawiS. Familial juvenile systemic lupus erythematosus in Arab children. Rheumatol Int2012; 32: 1939–1943.
41.
MarksSDPatteySBroganPA. B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus. Arthritis Rheum2005; 52: 3168–3174.
42.
PodolskayaAStadermannMPilkingtonCMarksSDTullusK. B cell depletion therapy for 19 patients with refractory systemic lupus erythematosus. Arch Dis Child2008; 93: 401–406.
